Skip to main content
. 2013 Dec 16;17(6):R297. doi: 10.1186/cc13163

Table 4.

Effects of gabexate mesilate on the outcome of the patients

  Survivors Nonsurvivors Mortality (%) P value
Gabexate mesilate and antithrombin
14
2
12.5
 
Gabexate mesilate
15
2
11.8
 
 
 
 
 
1.000
Use of gabexate mesilate
29
4
12.1
 
Nonuse of gabexate mesilate
24
3
11.1
 
        1.000